Dedifferentiated and undifferentiated neoplasms: A conceptual approach

被引:11
作者
Baraban, Ezra [1 ]
Cooper, Kumarasen [1 ]
机构
[1] Univ Penn, Hosp Univ Penn HUP, Perelman Sch Med, Dept Pathol, 6 Founders,3400 Spruce St, Philadelphia, PA 19104 USA
关键词
Dedifferentiated carcinoma; Dedifferentiated sarcoma; Dedifferentiated melanoma; Undifferentiated carcinoma; THYROID MICROCARCINOMA; ENDOMETRIAL CARCINOMA; DIAGNOSTIC UTILITY; CHONDROSARCOMA; DIFFERENTIATION; MUTATION; FEATURES; DISTINCTION; LIPOSARCOMA; EXPRESSION;
D O I
10.1053/j.semdp.2020.09.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This review provides a conceptual approach to dedifferentiation across a variety of tumor types, with particular attention to genetic events that tie together morphologically disparate areas of these neoplasms. First, working definitions of the terms differentiated, undifferentiated, and dedifferentiated are developed. Then, specific ex-amples of tumors with a particular propensity for undergoing dedifferentiation are highlighted, with emphasis on both immunohistochemical studies and molecular lesions that enable surgical pathologists to establish diagnostic clarity in morphologically vexing situations. Throughout this review, the historical arc of the literature is fol-lowed, and therefore the discussion of specific tumor types begins with dedifferentiated chondrosarcoma, the neoplasm that inspired the terminology regarding dedifferentiation that remains in use today. Selected other sarcomas with well-established pathways of dedifferentiation are subsequently discussed, followed by de-scriptions of this process in subtypes of carcinoma and melanoma.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 39 条
[1]  
Agaimy Abbas, 2019, Surg Pathol Clin, V12, P149, DOI 10.1016/j.path.2018.10.006
[2]   Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant [J].
Agaimy, Abbas ;
Michal, Michael ;
Hadravsky, Ladislav ;
Michal, Michal .
HUMAN PATHOLOGY, 2018, 77 :20-27
[3]   Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma) Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker [J].
Agaimy, Abbas ;
Specht, Katja ;
Stoehr, Robert ;
Lorey, Thomas ;
Maerkl, Bruno ;
Niedobitek, Gerald ;
Straub, Melanie ;
Hager, Thomas ;
Reis, Anna-Carinna ;
Schilling, Bastian ;
Schneider-Stock, Regine ;
Hartmann, Arndt ;
Mentzel, Thomas .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (02) :181-191
[4]   Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology [J].
Akhtar, Mohammed ;
Al Hyassat, Samir ;
Elaiwy, Orwa ;
Rashid, Sameera ;
Al-Nabet, Ajayeb D. M. H. .
ADVANCES IN ANATOMIC PATHOLOGY, 2019, 26 (06) :421-427
[5]   Detection of driver mutations in BRAF can aid in diagnosis and early treatment of dedifferentiated metastatic melanoma [J].
Alrabadi, Nasr ;
Gibson, Natasha ;
Curless, Kendra ;
Cheng, Liang ;
Kuhar, Matthew ;
Chen, Shaoxiong ;
Warren, Simon J. P. ;
Alomari, Ahmed K. .
MODERN PATHOLOGY, 2019, 32 (03) :330-337
[6]   IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours [J].
Amary, M. Fernanda ;
Bacsi, Krisztian ;
Maggiani, Francesca ;
Damato, Stephen ;
Halai, Dina ;
Berisha, Fitim ;
Pollock, Robin ;
O'Donnell, Paul ;
Grigoriadis, Anita ;
Diss, Tim ;
Eskandarpour, Malihe ;
Presneau, Nadege ;
Hogendoorn, Pancras C. W. ;
Futreal, Andrew ;
Tirabosco, Roberto ;
Flanagan, Adrienne M. .
JOURNAL OF PATHOLOGY, 2011, 224 (03) :334-343
[7]   Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathologic Features with BRAFV600E Mutational Analysis [J].
Bernstein, Jane ;
Virk, Renu K. ;
Hui, Pei ;
Prasad, Avinash ;
Westra, William H. ;
Tallini, Giovanni ;
Adeniran, Adebowale J. ;
Udelsman, Robert ;
Sasaki, Clarence T. ;
Roman, Sanziana A. ;
Sosa, Julie A. ;
Prasad, Manju L. .
THYROID, 2013, 23 (12) :1525-1531
[8]   Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone [J].
Chen, Shaoxiong ;
Fritchie, Karen ;
Wei, Shi ;
Ali, Naser ;
Curless, Kendra ;
Shen, Tiansheng ;
Brini, Anna T. ;
Latif, Farida ;
Sumathi, Vaiyapuri ;
Siegal, Gene P. ;
Cheng, Liang .
HUMAN PATHOLOGY, 2017, 65 :239-246
[9]   BRAF mutation in 'sarcomas': a possible method to detect de-differentiated melanomas [J].
Cipriani, Nicole A. ;
Letovanec, Igor ;
Hornicek, Francis J. ;
Mullen, John T. ;
Duan, Zhenfeng ;
Borger, Darrell R. ;
Nielsen, Gunnlaugur Petur .
HISTOPATHOLOGY, 2014, 64 (05) :639-646
[10]  
DAHLIN DC, 1971, CANCER, V28, P461, DOI 10.1002/1097-0142(197108)28:2<461::AID-CNCR2820280227>3.0.CO